Ligustrazine ameliorates acute kidney injury through downregulation of NOD2mediated inflammation
Document Type: Research Article
Affiliations: 1: School of Basic Medical Sciences, Binzhou Medical University, Yantai, Shandong 264003, P.R. China 2: Center for Reproductive Medicine, National Research Center for Assisted Reproductive Technology and Reproductive Genetics, Shandong University, The Key Laboratory of Reproductive Endocrinology, Shandong University, Ministry of Education, Shandong Provincial Key Laboratory of Reproductive Medicine, Jinan, Shandong 250021, P.R. China 3: Microwave Treatment Department, Central Hospital of Zibo (GaoQing Branch Courts), Zibo, Shandong 256300, P.R. China 4: Department of Anesthesiology and Shandong Provincial Medicine and Health Key Laboratory of Clinical Anesthesia, Weifang Medical University, Weifang, Shandong 261053, P.R. China 5: Department of Gerontology, The Second Hospital of Shandong University, Jinan, Shandong 250000, P.R. China
Publication date: 01 January 2020
- The International Journal of Molecular Medicine is a monthly, peer-reviewed journal devoted to the publication of high quality studies related to the molecular mechanisms of human disease. The journal welcomes research on all aspects of molecular and clinical research, ranging from biochemistry to immunology, pathology, genetics, human genomics, microbiology, molecular pathogenesis, molecular cardiology, molecular surgery and molecular psychology.
The International Journal of Molecular Medicine aims to provide an insight for researchers within the community in regard to developing molecular tools and identifying molecular targets for the diagnosis and treatment of a diverse number of human diseases. - Editorial Board
- Information for Authors
- Submit a Paper
- Subscribe to this Title
- Information for Advertisers
- Terms & Conditions
- Ingenta Connect is not responsible for the content or availability of external websites
- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content